entering pregnancy with quiescent/low activity disease Patient participants expressed a strong desire that their physicians discuss family planning "early and often," including before planning of pregnancy. Discussion with patients should include information on medications and impact of disease activity, autoantibodies, and organ system abnormalities on maternal and fetal health. In rare situations with significant disease-related damage, such as pulmonary arterial hypertension, renal dysfunction, heart failure, or other severe organ damage, pregnancy may be contraindicated due to high risk of maternal morbidity and mortality. In women with RMD planning pregnancy who are receiving medication that is incompatible with pregnancy, we strongly recommend switching to a pregnancycompatible medication and observing for sufficient time to assess efficacy and tolerability of the new medication. There are no data to support a specific period of time for observation with pregnancy-compatible